FibroGen Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

FibroGen Stock Summary

FibroGen competes with Candel Therapeutics, Unicycive Therapeutics, Cardio Diagnostics, Virax Biolabs, and Senti Biosciences. FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California. Fibrogen Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 566 people.

FibroGen Key Financial Ratios

FibroGen Key Balance Sheet Accounts

FibroGen Key Income Statement Accounts

FibroGen Key Cash Accounts

FibroGen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining FibroGen's current stock value. Our valuation model uses many indicators to compare FibroGen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across FibroGen competition to find correlations between indicators driving FibroGen's intrinsic value. More Info.FibroGen is rated below average in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . At this time, FibroGen's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the FibroGen's earnings, one of the primary drivers of an investment's value.

FibroGen Systematic Risk

Today, most investors in FibroGen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various FibroGen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of FibroGen growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of FibroGen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of FibroGen. We use our internally-developed statistical techniques to arrive at the intrinsic value of FibroGen based on widely used predictive technical indicators. In general, we focus on analyzing FibroGen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build FibroGen's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.